BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Prognosis
3 results:

  • 1. Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in colorectal cancer.
    Nearchou IP; Lillard K; Gavriel CG; Ueno H; Harrison DJ; Caie PD
    Cancer Immunol Res; 2019 Apr; 7(4):609-620. PubMed ID: 30846441
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer.
    Dallol A; Al-Maghrabi J; Buhmeida A; Gari MA; Chaudhary AG; Schulten HJ; Abuzenadah AM; Al-Ahwal MS; Sibiany A; Al-Qahtani MH
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2069-75. PubMed ID: 23010642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hypermethylation of the myod1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.